GENETIC-AF Phase 2B Clinical Trial Results Presented in Late Breaking Presentation at European Society of Cardiology Heart Failure 2018 World Congress Posted on May 29, 2018 by ARCA IT - Press Release, Uncategorized ESC Heart Failure 2018 - GENETIC-AF Data Presentation - FINAL
ARCA biopharma Announces Phase 2B GENETIC-AF Clinical Trial Results Selected for Late Breaking Oral Presentation at European Society of Cardiology Heart Failure 2018 World Congress Posted on May 10, 2018 by ARCA IT - Press Release, Uncategorized ESC Heart Failure 2018 - GENETIC-AF Late Breaker Acceptance - FINAL
ARCA biopharma Announces First Quarter 2018 Financial Results and Provides Corporate Update Posted on May 8, 2018 by ARCA IT - Press Release, Uncategorized ABIO - 1Q18 Financial Results and Business Update - FINAL